Chongqing Haifu - Tumors, Osteosarcoma, and Cancer Treatments

Chongqing Haifu Medical Technology Co., Ltd is the world first and leading manufacturer of noninvasive ultrasound therapeutic systems. Since 1999, the Haifu systems have been installed in many countries all around the world, including UK, Spain, Italy, Saudi Arabia, Russia, Rumania, Kazakhstan, Ukraine, South Korea, Japan, Hong Kong and Mainland China, offering noninvasive solution to patients with benign and malignant tumors. The indications suitable for HIFU treatment are uterine fibroids, osteosarcoma, liver cancer, kidney cancer, pancreas cancer, breast cancer, fibroid tumors, tumor symptoms, soft tissue and metastatic cancers, etc. The past ten years has witnessed the great success of HIFU cancer treatment—more than 40000 cases been treated and many patients survived more than ten years.